Wednesday, June 7, 2017
- 1:15pm-2:45pm
-
Neuroprotective effects of antidepressant mirtazapine against dopaminergic neurodegeneration in cultured cells and in parkinsonian mice possibly by targeting astrocytes
Neuropharmacology · Exhibit Hall C
- 1:15pm-2:45pm
-
Neuropsychological profile of corticobasal degeneration, progressive supranuclear palsy and frontotemporal dementia patients
Cognitive Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Neuroticism and depression is associated with impulse control disorder in Parkinson’s disease: a controlled study
Neuropharmacology · Exhibit Hall C
- 1:15pm-2:45pm
-
Neurotological Findings in Sporadic Ataxia
Ataxia · Exhibit Hall C
- 1:15pm-2:45pm
-
New XK deletion associated with McLeod syndrome
Choreas (Non-Huntington’s Disease) · Exhibit Hall C
- 1:15pm-2:45pm
-
Non-Progressive Coreoatethosis Secondary to Infantile Necrotizing Encephalopathy Mimicking Leigh Disease.
Choreas (Non-Huntington’s Disease) · Exhibit Hall C
- 1:15pm-2:45pm
-
Nutritional status and changes in body weight in patients with multiple system atrophy
Ataxia · Exhibit Hall C
- 1:15pm-2:45pm
-
Objective biomarkers of posture balance for early and advanced Parkinson’s disease
Phenomenology and Clinical Assessment Of Movement Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Objective measurement of upper extremity bradykinesia using the keyboard-based dexterity test
Phenomenology and Clinical Assessment Of Movement Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Onabotulinumtoxin A (Botox) displays superior activity to incobotulinumtoxinA (Xeomin) in multiple in vitro and in vivo assays
Neuropharmacology · Exhibit Hall C
- «Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 38
- Next Page»